NCT03888157 A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine Status COMPLETED Phase N/A
NCT03883412 Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007) Status RECRUITING Phase PHASE4
NCT03757130 Multiple Ascending Dose Study of AMG 598 in Adults With Obesity Status COMPLETED Phase PHASE1
NCT03707171 Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT03671733 Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients Status UNKNOWN Phase PHASE3
NCT03632759 Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D Status COMPLETED Phase EARLY_PHASE1
NCT03619330 Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism. Status COMPLETED Phase PHASE4
NCT03560336 A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea. Status COMPLETED Phase N/A
NCT03555994 A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE2
NCT03523273 Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity Status COMPLETED Phase PHASE2
NCT03500484 Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity. Status TERMINATED Phase EARLY_PHASE1
NCT03486392 A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants Status COMPLETED Phase PHASE2
NCT03479762 In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database Status COMPLETED Phase N/A
NCT03466021 Effects of Liraglutide in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE4
NCT03449654 Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes Status COMPLETED Phase PHASE4
NCT03292185 A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Status COMPLETED Phase PHASE1